Synklino (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Registration number:38778676
Business model:B2B

Synklino strives to provide rapid relief as well as to improve long-term survival for transplant recipients by providing fast and safe eradication of cytomegalovirus (CMV) infections. For transplant recipients, CMV disease causes suboptimal transplantation outcome, increased morbidity, prolonged hospitalization and increased mortality.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.48M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Synklino

Name Criteria
Denmark MedTrace
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
  • Total raised in a similar range: 1M - 5M USD
Denmark Octarine Bio
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
  • Total raised in a similar range: 1M - 5M USD
Denmark Cirqle Biomedical
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: BioInnovation Institute
  • Total raised in a similar range: 1M - 5M USD
Denmark RetiPharma
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: BioInnovation Institute
  • Total raised in a similar range: 1M - 5M USD
Denmark Antag Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Fidabio
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Galecto Biotech
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Eir Ventures
Denmark Cerebriu
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
  • Total raised in a similar range: 1M - 5M USD
Denmark Chromologics
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
  • Total raised in a similar range: 1M - 5M USD
Denmark Neurons
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
  • Total raised in a similar range: 1M - 5M USD
Top